View as an RSS Feed
- Buyout Buzz at ASH Hematology Confab
- 13 Biotechs to Watch for at Hematology Conference
- Developments for Parkinson's Disease Ignite Investor Enthusiasm
Healthcare Reform vs Innovation and Growth?
on Oct. 13, 2009 • 4 Comments
- 11 Ache-Free Investment Opportunities in Neuropathic Pain
- Bayer's Bold New Bet Fails to Rain on Spectrum Pharma
- Three Recent Biotech Activist Wins by Carl Icahn
- Cash for Cardiovascular: Who Might Be Next?
- Treating Parkinson’s Disease - Investment Opportunities and Challenges
- Genzyme's Manufacturing Disruption Highlights Investment Opportunities
- Can Spectrum Pharmaceuticals Benefit from FDA Action on Zevalin?
- Much Ado About Medarex
- ADA Meeting 2009: Novel Diabetes Therapies Presented
- Molecular Insight Pharmaceuticals: Two Promising Candidates to Battle Prostate Cancer
- Keryx: Another Beneficiary of the ASCO Effect
- Biotech Stocks and the ASCO-Effect
- Where Might Genentech Investors Redeploy $47B?
- Chink in the Biotechnology Armor
- Bullish Thesis for Biotech Remains Intact
- 2009: Positive Outlook for Biotech